Megan J. Fahey

Megan J. Fahey

Auto-generated profile, based on publicly available information

Megan J. Fahey

Baker Institute for Animal Health, Department of Microbiology and Immunology Cornell University Ithaca New York USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2024 in Veterinary Surgery
Verified
Journal Article
Open access
MFMegan J. Fahey
Megan J. Fahey
RHRebecca Harman
Rebecca Harman
MTMatthew A. Thomas
Matthew A. Thomas
BPBrenna Pugliese
Brenna Pugliese
JPJeanine Peters‐Kennedy
Jeanine Peters‐Kennedy
GWGerlinde Van de Walle
Gerlinde Van de Walle
Objective: We aimed to study the antimicrobial and pro‐healing potential of equine mesenchymal stromal cell secreted products (i.e. secretome), collected as conditioned media (mesenchymal stromal cell‐conditioned media, MSC CM), in a novel in vivo model of methicillin‐resistant Staphylococcus aureus (MRSA)‐inoculated equine thorax wounds.Study design: Prospective in vivo study.Animals: Two Thoroughbred geldings.Methods: Six full‐thickness cutaneous wounds were created bilaterally on the dorsal thorax of two horses (n = 12 wounds/horse). Wounds on the left thoraces were inoculated with MRSA on day 0. All wounds were then treated with either mupirocin ointment, MSC CM, or vehicle control (n = 4 wounds per group) once daily for 3 days. Photographs were taken to quantify wound scores and sizes, as well as samples to determine bacterial colony forming units (CFUs), at days 0, 1, 2, 3, 7, 14, 21, and 28. The wound edge was biopsied on days 0, 7, and 28, and scored histologically.Results: Inoculated wounds had more bacterial CFUs at day 1 (p < .0001) and were larger in size at day 28 (p = .0009) than noninoculated wounds. Mupirocin‐treated wounds were smaller than MSC CM and vehicle control‐treated wounds at day 28 (p = .003). Mesenchymal stromal cell‐conditioned media did not affect CFU numbers in inoculated and noninoculated wounds. Moreover, MSC CM did not affect the parameters of wound size or gross or microscopic wound scores over time.Conclusion: Mesenchymal stromal cell‐conditioned media did not exhibit antimicrobial or pro‐healing properties in the current study; however, the in vivo model of inoculated equine thorax wounds requires further optimization.Clinical significance: This pilot study contributes to a growing understanding of the equine MSC secretome as an antimicrobial and pro‐healing therapeutic for equine wounds.

13 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MFMegan J. Fahey
Megan J. Fahey
MBMaureen P. Bennett
Maureen P. Bennett
MTMatthew Thomas
Matthew Thomas
IVIrene Vivancos-Koopman
Irene Vivancos-Koopman
LBLindsay Browning
Lindsay Browning
MDMichelle L. Delco
Michelle L. Delco
Avascular soft tissues of the skeletal system, including articular cartilage, have limited healing capacity, in part due to their low metabolic activity. No drugs are available that can prevent or slow the development of osteoarthritis (OA) after joint injury. Therefore, mesenchymal stromal cell (MSC)-based regenerative therapies are increasingly common in the treatment of OA, but questions regarding their clinical efficacy and mechanisms of action remain unanswered. Our group recently reported that mitochondrial dysfunction is one of the earliest responses of cartilage to injury, resulting in chondrocyte death, extracellular matrix degeneration, and ultimately OA. MSCs have been found to rescue injured cells and improve healing by donating healthy mitochondria in highly metabolic tissues, but mitochondrial transfer has not been investigated in cartilage. Here, we demonstrate that MSCs transfer mitochondria to stressed chondrocytes in cell culture and in injured cartilage tissue. Conditions known induce chondrocyte mitochondrial dysfunction, including stimulation with rotenone/antimycin and hyperoxia, increased transfer. Stressed chondrocytes increased expression of genes related to inflammation and senescence, further supporting the link between mitochondrial dysfunction and transfer. MSC-chondrocyte mitochondrial transfer was blocked by non-specific and specific (connexin-43) gap-junction inhibition. When MSCs were exposed to mechanically injured cartilage they localized to areas of matrix damage and extended cellular processes deep into microcracks, delivering mitochondria to chondrocytes. This work provides insights into the chemical, environmental, and mechanical conditions that can elicit MSC-chondrocyte mitochondrial transfer in vitro and in situ, and our findings suggest a new potential role for MSC-based therapeutics after cartilage injury. Significance Statement Recent evidence suggests that although articular cartilage is avascular and relatively metabolically quiescent, acute injury induces chondrocyte mitochondrial dysfunction, driving cartilage degradation and OA. We present the first evidence that MSCs donate mitochondria to articular chondrocytes undergoing mitochondrial dysfunction in vitro and in situ. These findings support a new role for MSCs in the context of cartilage injury and OA, and intercellular mitochondrial transfer may represent a new biological approach to augment mitochondrial capacity in injured chondrocytes. This work establishes multiple experimental models to study MSC mitochondrial donation for the treatment of OA and related degenerative diseases of avascular orthopedic tissues.